Heartbeam, Inc. (BEAT)
Last updated: 2026-10-24 22:23:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Heartbeam, Inc. (BEAT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.40, with a market capitalization of $22.43M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.36 to $4.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$22.43M | |
$0.40 | |
$80.92 | |
$0.36 | |
$0.40 | |
540.14K | |
7.35M | |
-- | |
$4.00 | |
$0.36 | |
-- | |
-- |
Heartbeam, Inc. (BEAT) Latest Closing Stock Price
Heartbeam, Inc. (BEAT) last closed at $0.40 as of 2026-10-23 23:55:00, unchanged from the previous close of $0.40.
During the latest regular trading session, BEAT traded between $0.36 and $80.92, with a volume of 540.14K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Heartbeam, Inc. (BEAT) 7-Day Stock Price Change
Over the past seven days, Heartbeam, Inc. (BEAT) moved from $0.43 to $0.40, representing a decline of 8.46% ($0.04).
The stock traded between $0.39 and $0.44 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 641.20 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
BEAT 52-Week Price Position
Position in Range: 1.1%
BEAT is currently trading at $0.40, placing it 1.1% of the way from its 52-week low of $0.36 to its 52-week high of $4.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Heartbeam, Inc. (BEAT)?
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Heartbeam, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 16 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Heartbeam, Inc. (BEAT) Stock on MEXC
Eligible investors can buy real shares of Heartbeam, Inc. (BEAT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Heartbeam, Inc. (BEAT) stock price today?
2.Is BEAT stock going up or down today?
3.What is BEAT pre-market price?
4.What is BEAT after-hours price?
5.Is BEAT stock trading now?
6.Where does BEAT sit relative to its 52-week high and low?
7.What sector is Heartbeam, Inc. in?
8.What is Heartbeam, Inc.'s market capitalization and where is it listed?
9.How is BEAT valued in terms of P/E ratio and EPS?
10.Does Heartbeam, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BEAT Stock Calculator
Estimate the value between BEAT shares and USD.
BEAT Shares to USD
1.00 BEAT shares = 0.395 USD
Calculations are estimates based on the latest available price and are for reference only.


